Moxidectin toxicity to zebrafish embryos: Bioaccumulation and biomarker responses.
Aquatic toxicology
Emerging pollutants
MALDI-MS imaging
Macrocyclic lactones
Veterinary antiparasitics
Journal
Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476
Informations de publication
Date de publication:
15 Aug 2021
15 Aug 2021
Historique:
received:
10
12
2020
revised:
14
03
2021
accepted:
04
04
2021
pubmed:
19
4
2021
medline:
16
6
2021
entrez:
18
4
2021
Statut:
ppublish
Résumé
Moxidectin is an antiparasitic drug belonging to the class of the macrocyclic lactones, subgroup mylbemicins. It is used worldwide in veterinary practice, but little is known about its potential environmental risks. Thus, we used the zebrafish embryo as a model system to study the potential effects of moxidectin on aquatic non-target organisms. The analyses were performed in two experimental sets: (1) acute toxicity and apical endpoints were characterized, with biomarker assays providing information on the activity levels of catalase (CAT), glutathione S-transferase (GST), lactate dehydrogenase (LDH), and acetylcholinesterase (AChE); and (2) internal concentration and spatial distribution of moxidectin were determined using ultraperformance liquid chromatography quadrupole-time-of-flight mass spectrometry (UPLC-QToF-MS) and matrix-assisted laser desorption/ionization-MS imaging (MALDI-MSi). The acute toxicity to zebrafish embryos (96 hpf) appeared mainly as a decrease in hatching rates (EC
Identifiants
pubmed: 33866217
pii: S0269-7491(21)00678-3
doi: 10.1016/j.envpol.2021.117096
pii:
doi:
Substances chimiques
Biomarkers
0
Macrolides
0
Water Pollutants, Chemical
0
moxidectin
NGU5H31YO9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117096Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.